期刊论文

Yu, Yingjie(yuyingjie@mail.buct.edu.cn)

英文

Acta Biomaterialia

1742-7061

2023

160

198-210

10.1016/j.actbio.2023.02.012

Author contributions Author contributions are defined based on the CRediT (Contributor Roles Taxonomy) and listed alphabetically. Conceptualization: Y. H., Y.Y.; D. W.; formal analysis: Y. H., B.W., D.T.; funding acquisition: W. H., Y. Y.; investigation: Y. Y., Y. H., W. H.; methodology: D. W., Y. H., B.W., D.T., A.C., S. X.; project administration: Y. Y., W.H.; resources: Y. Y.; W. H.; software: Y. H., B.W.; supervision: W. H.; validation: Y. H.; visualization: B.W., Y. H., D. W.; writing – original draft: Y. H., Acknowledgements and This work was supported by National Natural Science Foundation of China (81172210, 82060500), Special Topic of Basic Application Research of Hengyang (2019YJ010631).

本校为其他机构

As a DNA damaging agent, oxaliplatin (OXA) can induce immunogenic cell death (ICD) in tumors to activate the immune system. However, the DNA damage induced by OXA is limited and the ICD effect is not strong enough to enhance anti-tumor efficacy. Here, we propose a strategy to maximize the ICD effect of OXA through the mild hyperthermia generated by nanoparticles with a platinum (IV) prodrug of OXA (Pt(IV)-C16) and a near-infrared-II (NIR-II) photothermal agent IR1061 upon the irradiation of NIR-II light. The mild hyperthermia (43 °C) holds adv...